Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eafc60c3028a59a748dc7eb0223784ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e58a010699a6e8bed79a7e9f3da3c7b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b804a68ef5216e2604d4e50641252f46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a67afe62105e3dbb71fa5e8387a05d4e |
publicationDate |
2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010092450-A1 |
titleOfInvention |
Use of Hyaluronidase for the Prevention or Treatment of Arterial Hypertension or Cardiac Insufficiency |
abstract |
The present invention relates to the use of hyaluronidase for the prevention and/or treatment of arterial hypertension or cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating arterial hypertension or cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012021048-A1 |
priorityDate |
2008-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |